Бизнес · 23.05.19941 мин чтения
Fujisawa USA, Inc., et al.; Withdrawal of Approval of 22 Abbreviated New Drug Applications
Локальный автоматический перевод · Язык оригинального источника
Краткое содержание
The Food and Drug Administration (FDA) is withdrawing approval of 22 abbreviated new drug applications (ANDA's). The holders of the ANDA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.